Go Pro

Arteris (NASDAQ:AIP) CEO Sells $2,216,820.00 in Stock

Arteris logo with Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Arteris CEO K. Charles Janac sold 73,894 shares at an average price of $30, generating $2.22 million. He retained 8.36 million shares worth approximately $250.7 million, a 0.88% reduction in ownership.
  • The sale follows several additional insider transactions, including more than $17.7 million in shares sold since May, indicating a pattern of substantial CEO selling.
  • Arteris shares fell 3.6% to $30.93, below their 50-day moving average of $36.29. Despite a quarterly earnings beat and a consensus “Moderate Buy” rating with a $38.50 price target, the company remains unprofitable and analysts expect a full-year loss.
  • MarketBeat previews top five stocks to own in September.

Arteris, Inc. (NASDAQ:AIP - Get Free Report) CEO K Charles Janac sold 73,894 shares of the firm's stock in a transaction that occurred on Monday, August 3rd. The stock was sold at an average price of $30.00, for a total transaction of $2,216,820.00. Following the completion of the transaction, the chief executive officer directly owned 8,355,177 shares in the company, valued at $250,655,310. This trade represents a 0.88% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

K Charles Janac also recently made the following trade(s):

  • On Tuesday, August 4th, K Charles Janac sold 26,106 shares of Arteris stock. The shares were sold at an average price of $31.97, for a total value of $834,608.82.
  • On Monday, July 6th, K Charles Janac sold 125,976 shares of Arteris stock. The stock was sold at an average price of $35.79, for a total value of $4,508,681.04.
  • On Monday, July 6th, K Charles Janac sold 10,679 shares of Arteris stock. The shares were sold at an average price of $35.90, for a total value of $383,376.10.
  • On Thursday, July 2nd, K Charles Janac sold 192,686 shares of Arteris stock. The stock was sold at an average price of $36.32, for a total value of $6,998,355.52.
  • On Thursday, July 2nd, K Charles Janac sold 10,902 shares of Arteris stock. The shares were sold at an average price of $38.78, for a total transaction of $422,779.56.
  • On Monday, June 8th, K Charles Janac sold 70,000 shares of Arteris stock. The stock was sold at an average price of $34.91, for a total transaction of $2,443,700.00.
  • On Friday, May 8th, K Charles Janac sold 70,000 shares of Arteris stock. The shares were sold at an average price of $31.20, for a total transaction of $2,184,000.00.

Arteris Trading Down 3.6%

Shares of Arteris stock traded down $1.16 during mid-day trading on Wednesday, hitting $30.93. The stock had a trading volume of 521,833 shares, compared to its average volume of 734,745. The firm has a 50-day moving average of $36.29 and a two-hundred day moving average of $25.97. The firm has a market cap of $1.43 billion, a P/E ratio of -39.15 and a beta of 1.96. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.17. Arteris, Inc. has a 12-month low of $8.42 and a 12-month high of $50.26.

Arteris (NASDAQ:AIP - Get Free Report) last released its quarterly earnings data on Tuesday, May 12th. The company reported ($0.03) EPS for the quarter, beating analysts' consensus estimates of ($0.08) by $0.05. The business had revenue of $22.94 million during the quarter, compared to analyst estimates of $21.03 million. Sell-side analysts forecast that Arteris, Inc. will post -0.6 earnings per share for the current year.

Wall Street Analyst Weigh In

AIP has been the topic of a number of recent analyst reports. TD Cowen lifted their price objective on shares of Arteris from $22.00 to $40.00 and gave the company a "buy" rating in a research note on Wednesday, May 13th. Rosenblatt Securities boosted their price target on shares of Arteris from $20.00 to $38.00 and gave the company a "buy" rating in a report on Wednesday, May 13th. Wall Street Zen lowered Arteris from a "buy" rating to a "hold" rating in a report on Saturday, May 2nd. Roth Capital started coverage on Arteris in a report on Tuesday. They issued a "buy" rating and a $40.00 target price on the stock. Finally, Weiss Ratings lowered Arteris from a "sell (d-)" rating to a "sell (e+)" rating in a research note on Wednesday, May 13th. Four investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $38.50.

Get Our Latest Stock Analysis on Arteris

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of AIP. Versant Capital Management Inc lifted its holdings in shares of Arteris by 33.7% during the second quarter. Versant Capital Management Inc now owns 1,150 shares of the company's stock worth $56,000 after buying an additional 290 shares in the last quarter. Raymond James Financial Inc. acquired a new stake in Arteris in the second quarter valued at $32,000. Royal Bank of Canada raised its stake in Arteris by 366.7% during the first quarter. Royal Bank of Canada now owns 4,023 shares of the company's stock worth $66,000 after buying an additional 3,161 shares during the last quarter. BNP Paribas Financial Markets lifted its position in shares of Arteris by 75.0% during the 3rd quarter. BNP Paribas Financial Markets now owns 6,053 shares of the company's stock valued at $61,000 after acquiring an additional 2,595 shares during the period. Finally, New York State Common Retirement Fund grew its stake in Arteris by 352.4% in the fourth quarter. New York State Common Retirement Fund now owns 9,500 shares of the company's stock valued at $147,000 after acquiring an additional 7,400 shares during the period. Institutional investors own 64.36% of the company's stock.

About Arteris

(Get Free Report)

Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company's core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.

Founded in 2003 and headquartered in Santa Clara, California, Arteris serves a global customer base across North America, Europe, and Asia.

Featured Stories

Insider Buying and Selling by Quarter for Arteris (NASDAQ:AIP)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Arteris Right Now?

Before you consider Arteris, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arteris wasn't on the list.

While Arteris currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines